New Oral Anticoagulants: Breakthrough or Just Another Bleeding Mess?

These slides were presented as part of a debate between Dr. Marc Carrier and Dr. Jafna Cox at the Family Medicine Forum 2013 in Vancouver. Dr. Carrier and Dr. Cox served as expert clinical advisors on CADTH’s Preventing Stroke in Patients with Atrial Fibrillation project that focused on the clinical and cost-effectiveness of warfarin, new oral anticoagulants (NOACs), and antiplatelets in the prevention of stroke in AFib.

View Debate Slides